Phathom Pharmaceuticals, Inc. financial data

Symbol
PHAT on Nasdaq
Location
Florham Park, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 235% % -59%
Quick Ratio 4% % -2.4%
Debt-to-equity -165% % 40%
Return On Equity 55% % -66%
Return On Assets -85% % 8.6%
Operating Margin -91% % 82%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78,798,712 shares 13%
Common Stock, Shares, Outstanding 71,419,025 shares 4.2%
Entity Public Float $555,500,000 USD
Common Stock, Value, Issued $6,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 72,918,764 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 72,918,764 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $175,110,000 USD 217%
Cost of Revenue $22,599,000 USD 183%
Research and Development Expense $32,780,000 USD -3.8%
Operating Income (Loss) $159,986,000 USD 42%
Nonoperating Income (Expense) $61,261,000 USD -7.7%
Net Income (Loss) Attributable to Parent $221,247,000 USD 34%
Earnings Per Share, Basic -3.03 USD/shares 43%
Earnings Per Share, Diluted -3.03 USD/shares 43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $129,972,000 USD -56%
Inventory, Net $5,518,000 USD 72%
Assets, Current $228,972,000 USD -36%
Property, Plant and Equipment, Net $1,064,000 USD -28%
Operating Lease, Right-of-Use Asset $2,603,000 USD 325%
Other Assets, Noncurrent $2,917,000 USD 72%
Assets $259,149,000 USD -32%
Accounts Payable, Current $4,983,000 USD -53%
Accrued Liabilities, Current $89,831,000 USD 69%
Contract with Customer, Liability, Current $27,249,000 USD 38%
Liabilities, Current $132,044,000 USD 54%
Contract with Customer, Liability, Noncurrent $350,122,000 USD 5.1%
Operating Lease, Liability, Noncurrent $2,065,000 USD
Other Liabilities, Noncurrent $4,000,000 USD -65%
Liabilities $697,318,000 USD 10%
Retained Earnings (Accumulated Deficit) $1,484,258,000 USD -18%
Stockholders' Equity Attributable to Parent $438,169,000 USD -73%
Liabilities and Equity $259,149,000 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $84,930,000 USD -23%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $18,000 USD 55%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 71,419,025 shares 4.2%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $84,948,000 USD -44%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,226,000 USD 40%
Deferred Tax Assets, Valuation Allowance $305,623,000 USD 20%
Deferred Tax Assets, Gross $306,278,000 USD 20%
Operating Lease, Liability $2,713,000 USD 442%
Payments to Acquire Property, Plant, and Equipment $18,000 USD -55%
Lessee, Operating Lease, Liability, to be Paid $3,696,000 USD 620%
Property, Plant and Equipment, Gross $4,539,000 USD 5.1%
Operating Lease, Liability, Current $648,000 USD 29%
Lessee, Operating Lease, Liability, to be Paid, Year Two $719,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $686,000 USD 34%
Operating Lease, Weighted Average Discount Rate, Percent 0.1383 pure 67%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $983,000 USD 8092%
Lessee, Operating Lease, Liability, to be Paid, Year Three $736,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $240,652,000 USD 23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40,000,000 shares 0%
Unrecognized Tax Benefits $3,675,000 USD 6.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four $753,000 USD
Operating Lease, Payments $200,000 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $177,000 USD -17%
Deferred Tax Assets, Net of Valuation Allowance $655,000 USD 337%
Share-based Payment Arrangement, Expense $28,719,000 USD 19%
Interest Expense $58,068,000 USD 54%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%